UK MHRA Response To Brexit Questions Still Leaves Gaps And Uncertainty For Medtech
As UK Prime Minister Theresa May tries to get her cabinet to accept the draft Brexit agreement between the UK and EU, Medtech Insight looks at the potential confusion for medtech should she fail.
You may also be interested in...
Questions outnumber answers for medtech following the UK's recently issued "technical notices" on the implications if the UK does not reach a Brexit agreement with the EU before March 2019. Below we list the critical outstanding questions based on a Medtech Insight analysis and discussion with several top experts in the field. These questions have also been put directly to the UK's MHRA and the European Commission.
"Expect and prepare for the worst," MedTech Europe's Serge Bernasconi recently said in Brussels. "Don't expect concessions." The words spoken by the association leader on Brexit leave delegates uncomfortable and revisiting what to do.
While the details of UK's Brexit deal are not finalized, those paralyzed in disbelief at the enormity of the fallout will have to act. The European Commission spells out the upheaval necessary for medtech to realign into the EU-27.